Loading organizations...
Key people at Logos Fund.
Logos Fund was founded in 2016 by Marco Streng (Founder).
Logos Capital is an investment firm focused on advancing healthcare through disciplined, data-driven biotechnology investments. The firm employs Logos Analytics, a proprietary data science platform, to predict clinical trial outcomes. This approach models clinical data and replicates statistical analyses, enabling rigorous diligence and risk management for investment decisions.
Founded in 2019 by Arsani William, Logos Capital emerged from the insight that combining scientific and clinical expertise with sophisticated data analytics is crucial for navigating complex biotechnology investments. William's background in medicine and business underpins this interdisciplinary strategy, bridging scientific innovation with investment success.
The firm targets private and public biotechnology companies, identifying transformative therapeutic advancements. Logos Capital's mission is to provide investors with robust returns while driving groundbreaking progress in healthcare. Its vision centers on offering financial foundations for innovations that elevate patient care and improve lives.
Logos Fund was founded in 2016 by Marco Streng (Founder).
Key people at Logos Fund.
Logos Fund has 2 tracked investments across 2 companies. The latest tracked deal is $20.0M Series A in Mia Labs in January 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 22, 2026 | Mia Labs | $20.0M Series A | Michael Gamson | Yossi J Levi, Eniac Ventures, J Ventures, Norwest Venture Partners, Vine Ventures |
| Sep 9, 2025 | Pathwork | $3.5M Seed | Mark Selcow | American Family Ventures, Meridian Ventures |
